News Powered By AI
News Powered By AI
Planet Labs CFO Ashley Johnson sold approximately 110,000 shares worth $2.4 million on July 23, 2026, through a pre-established trading plan that does not raise investor concerns.
GlobalFoundries director Marc Antaki sold 1,671 shares on July 29, 2026, at $49.02 per share to satisfy tax withholding obligations on vesting restricted stock units.
Three GlobalFoundries directors sold 1,671 shares each on July 29, 2026, through mandatory tax withholding arrangements related to equity vesting rather than discretionary sales decisions.
CoreWeave stock surged 21.5% intraday on July 30 following announcement of a partnership with Leidos to provide AI cloud services to U.S. federal agencies, diversifying the neocloud provider’s customer base.
IQVIA Chairman and CEO Ari Bousbib sold approximately 106,000 shares for $26.1 million through an exercise-and-sell of expiring stock appreciation rights, while the company reported record clinical bookings of $3.15 billion.
Novo Nordisk’s experimental heart drug Ziltivekimab failed its primary trial endpoint, causing the company’s shares to fall sharply as investors reassess the drugmaker’s pipeline beyond weight-loss medications.
